Saturday 17 October 2026
Export CAH’s income statement to Excel — free account
Cardinal Health, Inc.
CAH Healthcare Medical Distribution
Cardinal Health, Inc.’s revenue for fiscal 2026 (year ended June 2026) was $254.2 billion, up 14.2% from fiscal 2025. In the quarter to June 2026, revenue grew 5.84%, EPS grew 68.3%, free cash flow grew 10.9% and total debt rose 4.21%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years.
254.06
0.35
+0.14%
Follow CAH
| Jun '17 | Jun '18 | Jun '19 | Jun '20 | Jun '21 | Jun '22 | Jun '23 | Jun '24 | Jun '25 | Jun '26 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
4 | 6 | 7 | 6 | 8 | 5 | 7 | 6 | 6 | 7 |
P/E ratio |
19.15 | 64.67 | 10.50 | 0.00 | 27.32 | 0.00 | 93.63 | 28.62 | 25.93 | 32.72 |
Altman Z-Score |
4.25 | 3.92 | 4.20 | 3.76 | 4.05 | 4.34 | 5.08 | 5.39 | 4.73 | 5.09 |
P/S ratio |
0.19 | 0.11 | 0.10 | 0.10 | 0.10 | 0.08 | 0.12 | 0.11 | 0.18 | 0.22 |
Altman Z″-Score (non-manufacturers) |
2.14 | 0.86 | 1.22 | (0.16) | 0.71 | 0.23 | 0.00 | (0.02) | (0.03) | (0.22) |
P/FCF ratio |
30.99 | 6.45 | 5.96 | 9.64 | 8.22 | 5.17 | 10.45 | 7.34 | 21.85 | 12.31 |
P/Operating CF |
34.12 | 27.77 | 28.20 | 63.72 | 25.07 | 4.79 | 28.60 | 11.50 | 26.64 | 33.13 |
Beneish M-Score |
(2.44) | (2.74) | (2.50) | (3.11) | (2.59) | (2.77) | (2.74) | (2.67) | (2.32) | (2.74) |
Dividend Safety Score |
— | — | — | — | — | — | — | — | — | 86 |
P/B ratio |
3.62 | 2.54 | 2.25 | 8.53 | 9.29 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
0.22 | 0.17 | 0.14 | 0.13 | 0.12 | 0.08 | 0.12 | 0.11 | 0.20 | 0.24 |
EV/EBITDA |
9.95 | 19.55 | 6.46 | 0.00 | 15.54 | 178.60 | 17.53 | 12.24 | 14.73 | 16.84 |
EV/Operating CF |
23.83 | 8.18 | 7.26 | 9.84 | 8.03 | 4.78 | 8.90 | 6.36 | 18.83 | 11.61 |
EV/FCF |
35.40 | 9.49 | 8.26 | 12.16 | 9.61 | 5.39 | 10.71 | 7.33 | 24.36 | 13.19 |
Quick Ratio |
0.70 | 0.42 | 0.46 | 0.47 | 0.45 | 0.50 | 0.45 | 0.48 | 0.44 | 0.43 |
Current Ratio |
1.34 | 1.07 | 1.07 | 1.10 | 1.12 | 1.08 | 1.00 | 0.98 | 0.94 | 0.88 |
Net Debt/EBITDA |
1.24 | 6.26 | 1.80 | (1.26) | 2.25 | 7.04 | 0.43 | (0.02) | 1.52 | 1.13 |
Debt/Assets |
25.91% | 22.56% | 19.61% | 16.62% | 14.03% | 12.11% | 10.84% | 11.29% | 16.05% | 15.51% |
Debt/Equity |
1.52 | 1.49 | 1.27 | 3.78 | 3.48 | (7.53) | (1.59) | (1.59) | (3.24) | (3.26) |
Asset Turnover |
3.50 | 3.42 | 3.60 | 3.74 | 3.81 | 4.11 | 4.70 | 5.13 | 4.53 | 4.61 |
Operating CF/Net income |
0.92 | 10.81 | 2.00 | (0.53) | 3.98 | (3.38) | 8.62 | 4.42 | 1.54 | 3.02 |
Capex/Depreciation |
(0.54) | (0.37) | (0.33) | (0.41) | (0.51) | (0.51) | (0.70) | (0.70) | (0.69) | (0.65) |
Interest Coverage |
10.55 | 0.38 | 7.01 | (17.22) | 2.62 | (4.13) | 8.95 | 24.37 | 10.58 | 7.51 |
| 19.23% | 3.97% | 22.00% | (91.01%) | 34.08% | (172.43%) | (18.02%) | (27.62%) | (53.40%) | (63.98%) | |
| 3.47% | 0.64% | 3.37% | (9.04%) | 1.43% | (2.12%) | 0.76% | 1.93% | 3.18% | 3.10% | |
ROIC |
12.81% | 0.59% | 10.88% | (44.19%) | 6.38% | 0.00% | 0.00% | 0.00% | 70.42% | 125.05% |
Return on Tangible Assets |
14.31% | 6.17% | 34.13% | (78.79%) | 10.56% | (19.76%) | 13.43% | 48.05% | 467.37% | (80.85%) |
Average Days of Receivables |
22.60 | 20.81 | 21.19 | 19.72 | 20.45 | 21.26 | 19.78 | 19.45 | 21.72 | 19.83 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
2.90% | 3.36% | 3.08% | 2.99% | 2.79% | 2.49% | 2.34% | 2.20% | 2.47% | 2.52% |
Intangible Assets out of Total Assets |
0.23 | 0.31 | 0.29 | 0.28 | 0.23 | 0.17 | 0.14 | 0.14 | 0.23 | 0.24 |
Share Based Compensation of Revenue |
0.07% | 0.06% | 0.06% | 0.06% | 0.05% | 0.04% | 0.05% | 0.05% | 0.11% | 0.14% |
Graham Net Nets |
(0.20) | (0.61) | (0.62) | (0.85) | (0.70) | (0.80) | (0.51) | (0.56) | (0.48) | (0.38) |
Graham Number |
44.41 | 18.19 | 46.37 | 0.00 | 17.00 | 13.98 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
5.22% | 1.55% | 9.52% | (23.86%) | 3.66% | (6.57%) | 1.07% | 3.49% | 3.86% | 3.06% |
Free Cash Flow Yield |
3.23% | 15.50% | 16.78% | 10.38% | 12.17% | 19.33% | 9.57% | 13.62% | 4.58% | 8.13% |
Revenue per Share |
410.02 | 437.09 | 485.11 | 521.92 | 556.39 | 649.91 | 785.36 | 925.82 | 923.56 | 1,077.32 |
Operating CF per Share |
3.74 | 8.84 | 9.07 | 6.69 | 8.32 | 11.38 | 10.90 | 15.36 | 9.95 | 21.92 |
Capex per Share |
(1.22) | (1.23) | (1.09) | (1.27) | (1.37) | (1.28) | (1.84) | (2.04) | (2.26) | (2.62) |
Free Cash Flow per Share |
2.51 | 7.62 | 7.98 | 5.42 | 6.95 | 10.10 | 9.05 | 13.32 | 7.69 | 19.31 |
Cash per Share |
21.70 | 5.63 | 8.44 | 9.46 | 11.67 | 16.91 | 15.62 | 20.95 | 16.07 | 20.58 |
Shareholders Equity per Share |
21.54 | 19.36 | 21.10 | 6.12 | 6.14 | (2.53) | (11.33) | (13.11) | (10.93) | (11.54) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
21.54 | 19.36 | 21.10 | 6.12 | 6.14 | (2.53) | (11.33) | (13.11) | (10.93) | (11.54) |
Free Cash Flow |
797.00 | 2,384.00 | 2,394.00 | 1,587.00 | 2,029.00 | 2,819.00 | 2,363.00 | 3,263.00 | 1,853.00 | 4,556.00 |
Working Capital |
7,124.00 | 1,660.00 | 1,638.00 | 2,325.00 | 3,424.00 | 2,385.00 | (3.00) | (756.00) | (2,524.00) | (5,151.00) |
Capital Expenditures |
(387.00) | (384.00) | (328.00) | (373.00) | (400.00) | (356.00) | (481.00) | (499.00) | (544.00) | (618.00) |
Net Current Asset Value |
(4,939.00) | (9,339.00) | (8,886.00) | (13,034.00) | (11,611.00) | (11,649.00) | (12,569.00) | (13,449.00) | (19,383.00) | (21,270.00) |
EV/EBIT |
13.31 | 179.63 | 9.60 | 0.00 | 41.31 | 0.00 | 33.65 | 19.24 | 19.84 | 23.00 |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Price to Operating Income |
11.65 | 122.09 | 6.93 | 0.00 | 35.32 | 0.00 | 32.82 | 19.27 | 17.80 | 21.46 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.38 | 0.42 | 0.42 | 0.39 | 0.33 | 0.29 | 0.28 | 0.28 | 0.28 | 0.32 |
Cash ROIC |
3.31% | 14.16% | 14.17% | 14.00% | 17.74% | 30.23% | 40.60% | 46.53% | 18.97% | 41.35% |
Accounts Receivable Turnover |
16.82 | 17.27 | 17.91 | 18.30 | 18.71 | 18.44 | 18.92 | 19.56 | 17.58 | 18.79 |
Accounts Payable Turnover |
7.01 | 6.90 | 6.73 | 6.81 | 6.91 | 6.88 | 6.94 | 7.11 | 6.45 | 6.70 |
Inventory Turnover |
11.26 | 10.98 | 11.04 | 11.23 | 11.20 | 11.57 | 12.48 | 14.12 | 13.49 | 14.33 |
Average Days of Payables |
52.95 | 55.41 | 56.67 | 53.42 | 55.56 | 56.63 | 55.15 | 52.83 | 59.09 | 57.16 |
Days of Inventory on Hand |
33.42 | 34.66 | 33.74 | 32.98 | 34.21 | 32.64 | 29.70 | 24.88 | 28.65 | 25.82 |
Average Receivables |
7,726.50 | 7,924.00 | 8,124.00 | 8,356.00 | 8,683.50 | 9,832.00 | 10,834.50 | 11,596.00 | 12,663.00 | 13,528.50 |
Average Payables |
17,606.00 | 18,791.50 | 20,606.00 | 21,454.50 | 22,537.00 | 25,414.00 | 28,531.00 | 30,846.50 | 33,236.00 | 36,498.00 |
Average Inventory |
10,958.00 | 11,804.50 | 12,565.00 | 13,010.00 | 13,896.00 | 15,115.00 | 15,877.50 | 15,538.00 | 15,894.00 | 17,064.00 |
Average Assets |
37,117.00 | 40,031.50 | 40,457.00 | 40,864.50 | 42,609.50 | 44,165.50 | 43,613.50 | 44,235.00 | 49,121.50 | 55,210.50 |
Average Common Equity |
6,699.50 | 6,443.50 | 6,194.50 | 4,061.00 | 1,793.00 | 544.00 | (1,831.50) | (3,084.50) | (2,923.00) | (2,679.00) |
Columns are period end dates